Boditech Med Inc. (KOSDAQ:206640)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,580.00
+80.00 (0.94%)
Oct 23, 2026, 3:30 PM KST

Boditech Med Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
174,776162,093138,160134,219118,077157,708
Revenue Growth
16.99%17.32%2.94%13.67%-25.13%9.42%
Gross Profit
101,95195,53181,29480,49570,63498,192
Operating Income
26,97328,94026,12928,25724,67151,936
Net Income
25,95023,65327,26025,94724,15244,367
Earnings Per Share
1199.821091.001242.001181.001079.941936.26
EPS Growth
2.63%-12.16%5.17%9.36%-44.23%-2.01%

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
South Korea
14,92613,50112,2369,4816,2265,622
America
23,00424,08917,56018,61319,48031,976
Europe
42,09232,38827,04727,02122,23024,167
Asia (Excl. China)
28,89328,87125,73424,33621,17532,561
China
14,85612,46816,13018,00420,06416,918
Middle East and North Africa (MENA)
37,36138,00829,35024,94419,07032,244
Africa
13,64312,76810,10411,8209,83114,220
Total
174,776162,093138,160134,219118,077157,708

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
52,91437,72361,71576,19860,45968,469
Total Debt
17,76417,74911,08710,5688,8956,866
Net Cash (Debt)
35,15019,97550,62965,63051,56461,603
Net Cash Growth
-29.26%-60.55%-22.86%27.28%-16.30%30.40%
Net Cash Per Share
1625.17921.692307.552987.512305.672688.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
14,81922,08124,87934,30023,06849,927
Capital Expenditures
-35,398-33,013-11,427-4,605-15,260-18,230
Free Cash Flow
-20,580-10,93213,45229,6957,80831,697
Free Cash Flow Growth
---54.70%280.32%-75.37%-21.86%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.33%58.94%58.84%59.97%59.82%62.26%
Operating Margin
15.43%17.85%18.91%21.05%20.89%32.93%
Pretax Margin
18.29%17.14%23.45%23.52%22.84%35.53%
Profit Margin
14.85%14.59%19.73%19.33%20.45%28.13%
FCF Margin
-11.77%-6.74%9.74%22.12%6.61%20.10%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
150.000150.000150.000200.000150.000200.000
Dividend Per Share Growth
0%0%-25.00%33.33%-25.00%0%
Dividend Yield
1.75%1.13%0.89%0.98%1.46%1.18%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.1512.0813.5317.369.328.62
Forward PE
-9.3010.8615.5923.4523.45
P/FCF Ratio
--27.4115.1728.8412.06
PS Ratio
1.071.762.673.361.912.42